The evaluation of oxidative stress and the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
Not Applicable
- Conditions
- Idiopathic pulmonary fibrosis (IPF)
- Registration Number
- JPRN-UMIN000016826
- Lead Sponsor
- ational Hospital Organization Ibarakihigashi National Hospital
- Brief Summary
Because we won't be able to collect the number of participants enough to analyze the data of the primary endpoint, we couldn't help but terminate this study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. The patients who disagree with involving in this study. 2. The patients had taken oral steroid medication and immunosuppressive therapy. 3. The patients who diagnosed as respiratory disorders other than IPF, malignancy, overt cardiac failure, and hepatic and renal disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method